CN101461524A - Sphallerocarpus gracills polysaccharide lozenge and technique for producing the same - Google Patents

Sphallerocarpus gracills polysaccharide lozenge and technique for producing the same Download PDF

Info

Publication number
CN101461524A
CN101461524A CNA2007103072891A CN200710307289A CN101461524A CN 101461524 A CN101461524 A CN 101461524A CN A2007103072891 A CNA2007103072891 A CN A2007103072891A CN 200710307289 A CN200710307289 A CN 200710307289A CN 101461524 A CN101461524 A CN 101461524A
Authority
CN
China
Prior art keywords
gracilis polysaccharide
lozenge
sphallerocerpus gracilis
sphallerocerpus
aspartame
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007103072891A
Other languages
Chinese (zh)
Inventor
邸多隆
黄新异
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lanzhou Institute of Chemical Physics LICP of CAS
Original Assignee
Lanzhou Institute of Chemical Physics LICP of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lanzhou Institute of Chemical Physics LICP of CAS filed Critical Lanzhou Institute of Chemical Physics LICP of CAS
Priority to CNA2007103072891A priority Critical patent/CN101461524A/en
Publication of CN101461524A publication Critical patent/CN101461524A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a yellow ginseng polysaccharide buccal tablet and production process thereof. The buccal tablet contains 60-70% of yellow ginseng polysaccharide extract, 27-37% of D- mannite, 0.1-0.5% of aspartame, 0.3-1.0% of L- menthol, 0.3-1.0% of superfine silica gel powder, and 0.4-1.5% of magnesium stearate. The yellow ginseng polysaccharide buccal tablet is convenient for eating, slightly sweet and cool, light fragrant, great in mouth feeling, having reinforced immunity, and functions of lowering blood pressure, blood sugar and cholesterin.

Description

A kind of Sphallerocerpus gracilis polysaccharide lozenge and production technology thereof
Technical field
The present invention relates to a kind of is Sphallerocerpus gracilis polysaccharide lozenge and the production technology thereof that main component is mixed with the Sphallerocerpus gracilis polysaccharide.
Background technology
Yellow ginseng is the meat rhizome of samphire Sphallerocarpus gracilis (Sphallerocarpus gracilis), and all there is distribution ground and Mongolia and east, former Soviet Union Siberia and the Far East Area in China Heilungkiang, Jilin, Gansu, Xinjiang, Qinghai etc.Yellow ginseng is nontoxic direct-edible, is a kind of pure natural health-care, and wherein polysaccharide is its main nutrient composition.Current STUDY ON POLYSACHAROSE is shown, polysaccharide can effectively strengthen human immune system's immunologic function, is a kind of effective immunopotentiator, also have simultaneously bring high blood pressure down, the effect of blood sugar and cholesterol, and certain antitumor action is arranged, thought good nutrient and healthcare products by international medical community.
Summary of the invention
The purpose of this invention is to provide a kind of enhancing body immunity that has, bring high blood pressure down, the health products Sphallerocerpus gracilis polysaccharide lozenge and the production technology thereof of blood sugar and cholesterol function.
A kind of Sphallerocerpus gracilis polysaccharide lozenge, in the quality percentage composition, form by Sphallerocerpus gracilis polysaccharide extract 60-70%, D-mannitol 27-37%, Aspartame 0.1-0.5%, L-menthol 0.3-1.0%, superfine silica gel powder 0.3-1.0% and dolomol 0.4-1.5%.
In the Sphallerocerpus gracilis polysaccharide lozenge, Sphallerocerpus gracilis polysaccharide content 〉=72% in the Sphallerocerpus gracilis polysaccharide extract.
In the Sphallerocerpus gracilis polysaccharide lozenge, every tablet quality 0.6g contains Sphallerocerpus gracilis polysaccharide extract 0.36~0.42g.
Sphallerocerpus gracilis polysaccharide lozenge production technology, it is characterized in that: in the quality percentage composition, Sphallerocerpus gracilis polysaccharide extract 65-70%, D-mannitol 30-35%, Aspartame 0.1-0.5%, L-menthol 0.3-1.0%, superfine silica gel powder 0.3-1.0% and dolomol 0.4-1.5%; Take by weighing Sphallerocerpus gracilis polysaccharide, D-mannitol, Aspartame, the pulverizing of L-menthol respectively, cross 100 mesh sieves, mix; Adding distil water, the system softwood is granulated with 14 mesh sieves, 60 ℃ of following heated-air dryings, the whole grain of 16 mesh sieves adds superfine silica gel powder and dolomol, mixing, the tablet press machine compacting promptly gets the Sphallerocerpus gracilis polysaccharide lozenge in flakes.
The present invention more specifically production technology is as follows:
1. Sphallerocerpus gracilis polysaccharide extract, D-mannitol, Aspartame, L-menthol are pulverized through pulverizer respectively, crossed 100 mesh sieves; Above-mentioned material dropped in the Multidimensionblender according to prescription mixed 30 minutes;
2. after treating that mixing of materials evenly, slowly add distilled water as wetting agent, adjust humidity of materials, make softwood, the humidity of softwood should suit;
3. will go up in the softwood input oscillating granulator that makes in the step and granulate, and place hot air circulation drying oven carrying out drying below 60 ℃ wet granular, when moisture is reduced to 4.0-6.0% in the particle, stop drying with 14 eye mesh screens;
4. get the whole grain of dry good particle use pelletizing machine 16 orders in the step, get single-size;
5. get the good single-size of whole grain in the step, add superfine silica gel powder and dolomol, put in the Multidimensionblender and mixed 30 minutes according to formula ratio;
6. get the particle that mixes in the step and carry out compressing tablet with tablet press machine, oven dry promptly obtains Sphallerocerpus gracilis polysaccharide lozenge finished product after finishing.
Sphallerocerpus gracilis polysaccharide lozenge among the present invention is a main component with the Sphallerocerpus gracilis polysaccharide, and L-menthol, superfine silica gel powder and the dolomol integration compacting of being furnished with D-mannitol, Aspartame and trace form, and mobility of particle is good, and tablet surface is smooth.
The Sphallerocerpus gracilis polysaccharide lozenge that the present invention makes is convenient to eat, and is little sweet nice and cool, and light delicate fragrance is arranged, good mouthfeel, and have enhancing immunity, the effect of hypotensive, blood sugar and cholesterol.
The specific embodiment
Be embodiments of the invention below, but the present invention is not limited only to embodiment.
Embodiment 1:
Get the Sphallerocerpus gracilis polysaccharide extract 400g that pulverized 100 mesh sieves, D-mannitol 189g, Aspartame 1.8g, L-menthol 3.0g puts into Multidimensionblender and mixed 30 minutes.After treating fully to mix, slowly add an amount of water the material that mixes is made softwood, the humidity of softwood should suit, and with can be agglomerating but tack-free with hand-tight holding, split with the light finger pressure energy and to be advisable.To granulate with 14 eye mesh screens in the softwood input oscillating granulator that make; then wet granular is placed hot air circulation drying oven dry below 60 ℃; 0.5h stir once,, when moisture is reduced to 4.0-6.0% in the particle, stop drying to accelerate rate of drying.Dried particles gets single-size with the whole grain of pelletizing machine 16 orders, adds 2g superfine silica gel powder and dolomol 5g then, puts in the Multidimensionblender and mixes 30 minutes.Mix the back and take out, carry out compressing tablet, suppress 1000 altogether, promptly get the Sphallerocerpus gracilis polysaccharide lozenge with tablet press machine.

Claims (3)

1, a kind of Sphallerocerpus gracilis polysaccharide lozenge, in the quality percentage composition, form by Sphallerocerpus gracilis polysaccharide extract 60-70%, D-mannitol 27-37%, Aspartame 0.1-0.5%, L-menthol 0.3-1.0%, superfine silica gel powder 0.3-1.0% and dolomol 0.4-1.5%.
2, lozenge as claimed in claim 1 is characterized in that Sphallerocerpus gracilis polysaccharide content 〉=72% in the Sphallerocerpus gracilis polysaccharide extract.
3, the production technology of Sphallerocerpus gracilis polysaccharide lozenge according to claim 1, it is characterized in that: in the quality percentage composition, Sphallerocerpus gracilis polysaccharide extract 65-70%, D-mannitol 30-35%, Aspartame 0.1-0.5%, L-menthol 0.3-1.0%, superfine silica gel powder 0.3-1.0% and dolomol 0.4-1.5%; Take by weighing Sphallerocerpus gracilis polysaccharide, D-mannitol, Aspartame, the pulverizing of L-menthol respectively, cross 100 mesh sieves, mix; Adding distil water, the system softwood is granulated with 14 mesh sieves, 60 ℃ of following heated-air dryings, the whole grain of 16 mesh sieves adds superfine silica gel powder and dolomol, mixing, the tablet press machine compacting promptly gets the Sphallerocerpus gracilis polysaccharide lozenge in flakes.
CNA2007103072891A 2007-12-18 2007-12-18 Sphallerocarpus gracills polysaccharide lozenge and technique for producing the same Pending CN101461524A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007103072891A CN101461524A (en) 2007-12-18 2007-12-18 Sphallerocarpus gracills polysaccharide lozenge and technique for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007103072891A CN101461524A (en) 2007-12-18 2007-12-18 Sphallerocarpus gracills polysaccharide lozenge and technique for producing the same

Publications (1)

Publication Number Publication Date
CN101461524A true CN101461524A (en) 2009-06-24

Family

ID=40802473

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007103072891A Pending CN101461524A (en) 2007-12-18 2007-12-18 Sphallerocarpus gracills polysaccharide lozenge and technique for producing the same

Country Status (1)

Country Link
CN (1) CN101461524A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101978895A (en) * 2010-08-23 2011-02-23 张雪峰 Deer penis stew buccal tablets and preparation method thereof
CN102150839A (en) * 2010-12-29 2011-08-17 张雪峰 Method for preparing stewed food buccal tablets
CN108783435A (en) * 2018-06-24 2018-11-13 甘肃农业大学 A kind of formula of kurarinone lily composite chewable tablet is standby and preparation method thereof
CN113121718A (en) * 2021-05-13 2021-07-16 东南大学 Roselle polysaccharide PSGP-2 and preparation method and application thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101978895A (en) * 2010-08-23 2011-02-23 张雪峰 Deer penis stew buccal tablets and preparation method thereof
CN101978895B (en) * 2010-08-23 2013-04-24 张雪峰 Deer penis stew buccal tablets and preparation method thereof
CN102150839A (en) * 2010-12-29 2011-08-17 张雪峰 Method for preparing stewed food buccal tablets
CN108783435A (en) * 2018-06-24 2018-11-13 甘肃农业大学 A kind of formula of kurarinone lily composite chewable tablet is standby and preparation method thereof
CN113121718A (en) * 2021-05-13 2021-07-16 东南大学 Roselle polysaccharide PSGP-2 and preparation method and application thereof
CN113121718B (en) * 2021-05-13 2022-09-23 东南大学 Roselle polysaccharide PSGP-2 and preparation method and application thereof

Similar Documents

Publication Publication Date Title
CN104688797A (en) Cordyceps and maca tablet
CN103734474B (en) Beautifying health-care tea and preparation method thereof
CN103300287B (en) Health-care noodles made of mung bean hulls and production method thereof
CN103766907A (en) Pure maca tablets and preparation method thereof
CN103518990B (en) A kind of fattening pannage and preparation method thereof
CN106421371A (en) Formula of cordyceps militaris rhizoma polygonati tablet and preparation method thereof
CN105838541A (en) Preparation method of Chinese herbal medicine wine yeast
CN105288215A (en) High-activity dendrobium officinale kimura et migo freeze-drying powder buccal tablets and preparation process thereof
CN102860519A (en) Preparation method for reducing hardness of dietary fiber chewable tablets
CN101461524A (en) Sphallerocarpus gracills polysaccharide lozenge and technique for producing the same
CN101711811A (en) Method for preparing Chaenomeles speciosa Nakai buccal tablet
CN104224858B (en) Cordyceps militaris microcapsules, preparation and preparation method thereof
CN102630949B (en) Insoluble dietary fiber and manufacturing method for insoluble dietary fiber
CN103372047A (en) Eucommia bark buccal tablets and preparation method thereof
CN1850234A (en) Funingkang thin-coating tablet and preparing method
CN101147730A (en) Constitution of xylitol tablet containing selenium and vitamin E and manufacturing method thereof
CN106974218A (en) A kind of lycium ruthenicum lozenge and preparation method thereof
CN103783531A (en) Ultra-micro ginseng pearl powder tablet and production technology thereof
CN105433391A (en) Pure maca tablet and preparation method thereof
CN105011004A (en) Instant highland barley tablets and processing method thereof
CN103461989B (en) Safflower bee pollen tablet and preparation method thereof
CN101011421B (en) Pollen tablet and its preparing process
CN104783177A (en) Maca preparation
CN105614438A (en) Selenium enriched fruit and vegetable extract tablet accessorily treating diabetes and preparation method thereof
CN104605462A (en) Preparation method of Maca tea effervescent tablets

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20090624